'Novotech is committed to helping improve access to clinical trials, and partnering with ClinTrial Refer provides an avenue to support communication of trials for Novotech clients'.
We are very pleased to welcome Novotech to the ClinTrial Refer community!
Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase.
Recognized for its industry-leading contributions, Novotech has received numerous prestigious awards, including the Frost & Sullivan 2024 Global Biotech CRO of the year award, Clinical Trials Arena Excellence Awards 2024, 2024 Employer of Choice, 2024 Great Place to Work in the US, 2024 Brandon Hall Gold Award, CRO Leadership Award 2023, the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence 2023, the Asia-Pacific Contract Research Organization Company of the Year Award since 2006.
The Company offers a comprehensive suite of services including laboratories, Phase I facilities, drug development consulting, regulatory expertise, and has experience with over 5,000 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. With a presence in 34 office locations and a dedicated team of 3,000+ professionals worldwide, Novotech is a trusted end-to-end strategic partner of choice.
For more information or to speak to an expert team member visit www.Novotech-CRO.com
Novotech is committed to helping improve access to clinical trials, and partnering with ClinTrial Refer provides an avenue to support communication of trials for Novotech clients.
Novotech is the first CRO to join the rapidly growing ClinTrial Refer community and we applaud their efforts to support research sites and clinicians and patients with access to current clinical trial opportunities.
